You are here: Industry Insights > punch

News List

Wham! Alexion investors sucker-punched as PTO takes up Amgen's Soliris patent challenge fiercepharma
September 02, 2019
Alexion Pharmaceuticals investors were celebrating last week when word on the street said Amgen might buy out the company, but a week later, their mood is much different.
Kicking, Punching: Who's at Risk for a Violent Sleep Disorder? drugs
December 27, 2018
You've probably seen movies where a veteran returns home from the horrors of war and wakes in the middle of the night yelling.....
Mylan lands biosimilar sucker punch to Amgen’s blockbuster pharmafile
June 07, 2018
Mylan and Biocon have received FDA approval for their biosimilar to Amgen’s Neulasta (pegfilgrastim), setting the companies on track to snatch a chunk of the treatment’s $4.2 billion per year in sales, as recorded last year.
Nanotechnology Delivers a Two-Punch Combination With Big Potential for Patients With Rare Cancers biospace
March 15, 2018
Researchers from the Department of Endocrinology and Oncology at the National Cancer Institute (NCI) reported in the latest issue of the Journal of the National Cancer Institute (JNCI) that。。。
Pfizer's Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status fiercepharma
August 24, 2017
Pfizer has already spent $2.1 million on a national TV ad for its next-gen eczema med, PDE-4 blocker Eucrisa.
Rebiotix delivers a gut bug PUNCH in C. diff trial pharmafile
April 14, 2017
Rebiotix is one a new breed of companies that aims to use the human body’s microbiome to treat illnesses and conditions ...
A one-two punch hits pancreatic cancer where it hurts worldpharmanews
April 10, 2017
Australian scientists have uncovered a promising new approach to treating pancreatic cancer, by targeting the tissue around the tumour to make it 'softer' and more responsive to chemotherapy.